Grading and frequency of pulmonary hypertension in chronic obstructive pulmonary disease patients

 

Mahesh Deshmukh¹^*, Pankaj Palange², Harshal Patil³, Abhijeet Nashte⁴, Satyajeet Borade⁵, Mohit Singhal⁶

 

^1,4,5,6Jr. Resident, ²Professor and HOD, ³Assistant Professor, Department of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Sangli, Maharashtra, INDIA.

Email: passhyavadd@gmail.com

 

REFERENCES

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR SurveillSumm2002; 51:1-16.
2. BunyaminSertogullarindan1, Hasan Ali Gumrukcuoglu2, CengizhanSezgi3, Mehmet Ata Akil2 Frequency of Pulmonary Hypertension in Patients with COPD due to Biomass Smoke and Tobacco Smoke, International JournalofMedicalSciences, 2012; 9(6):406-412.
3. Kircher BJ, Himelman RB, Schiller NB: Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66: 493-496.
4. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am CollCardiol 2009; 54: 55-66.
5. Peinado VI, Barbera` JA, Ramı ́rez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol Lung Cell Mol Physiol 1998; 18:908–913.
6. Dinh-Xuan AT,Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR,Wells FC,Wallwork J. Impairment of endothelium- dependent pulmonary artery relaxation in chronic obstructive lung dis- ease. N Engl J Med 1991; 324:1539–1547.
7. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, Roca J, Rodriguez-Roisin R, Barbera JA. Enhanced expression of vascular en- dothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 1250–1256.
8. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003; 108:1839–1844.
9. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE; National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002; 166:314-322.
10. Chaouat A, NaeijeR, Weitzenblum E. Pulmonary hypertension in COPD.Eur Respir J. 2008; 32:1371-1385.
11. Zelikoff JT, Chi Chen L, Cohen MD, Schlesinger RB. The toxicology of inhaled wood smoke. J Toxicol Environ Health B Crit Rev 2002; 5: 269-282.
12. Montan ̃ o M, Becerril C, Ruiz V, Ramos C, Sansores RH, Gonza ́lez- Avila G. Matrix metalloproteinases activity in COPD associated with wood smoke. Chest 2004; 125: 466-472.
13. HuG,ZhouY,TianJ,YaoW,LiJ,LiB,RanP.RiskofCOPDfromex- posure to biomass smoke: a metaanalysis. Chest 2010; 138: 20-31.
14. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 549 - 555.
15. Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 543 - 548